Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Brain Neoplasms 5Neoplasms 3Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Ovarian Cysts 1Myofibroma 1Lung Neoplasms 1Liver Neoplasms 1Hematologic Diseases 1Endobronchial Metastases 1Encephalocele 1Ear Neoplasms 1Cholecystitis 1Breast Neoplasms 1Brain Injuries 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Remifentanil × Clear all
NCT00213239 2019-12-02

A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children

The Hospital for Sick Children

Phase 1/2 Completed
64 enrolled 5 charts

Hematologic Diseases, Neoplasms

NCT00405522 2019-03-08

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

The Hospital for Sick Children

Phase 3 Completed
34 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT02093143 2014-03-20

ENDOTANIL

Centre Hospitalier Universitaire de Besancon

Phase 3 Completed
256 enrolled

Ear Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡